Vimarsana
Biggest News Aggregation in the World

Page 8 - Jeff Borcherding News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Jeff Borcherding. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Jeff Borcherding Today - Breaking & Trending Today

Immunovia strengthens US organization to continue commercialization of its novel IMMray™ PanCan-d test - Vimarsana News

Immunovia strengthens US organization to continue commercialization of its novel IMMray™ PanCan-d test

/PRNewswire/ -- Immunovia (Nasdaq Stockholm: IMMNOV), the diagnostics company that has launched the world's first blood test dedicated to the early detection...

Immunovia Publishes Interim Report Jan-Sep 2022 - Vimarsana News

Immunovia Publishes Interim Report Jan-Sep 2022

/PRNewswire/ -- July-September 2022 Net sales amount KSEK 358 (377) divided by sales of tests KSEK 111 and royalties KSEK 247. Net earnings amount MSEK -23...

Immunovia AB: Immunovia Publishes Interim Report Jan-Sep 2022 - Vimarsana News

Immunovia AB: Immunovia Publishes Interim Report Jan-Sep 2022

LUND, Sweden, Nov. 10, 2022 /PRNewswire/ -- July-September 2022 Net sales amount KSEK 358 (377) divided by sales of tests KSEK 111 and royalties KSEK 247.Net earnings amount MSEK

Invitation to Immunovia's Q3 presentation - Vimarsana News

Invitation to Immunovia's Q3 presentation

/PRNewswire/ -- Immunovia will publish its third quarter 2022 results on November 10, 2022 at 8:30 am CET. Analysts, investors and media are invited to a...

Immunovia AB: Immunovia announces executive management team changes to accelerate execution of strategic priorities - Vimarsana News

Immunovia AB: Immunovia announces executive management team changes to accelerate execution of strategic priorities

LUND, Sweden, Oct. 19, 2022 /PRNewswire/ -- Immunovia AB (Nasdaq Stockholm: IMMNOV) today announced changes to its executive management team to accelerate the execution of its strategic priorities.